Improving public health responses to COVID-19 through standardized testing.
THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE
This study is looking to improve how we fight COVID-19 by testing blood samples to see if people have had the virus, and it’s designed for anyone interested in better ways to manage the disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-11220317 on NIH RePORTER |
What this research studies
This research focuses on enhancing public health strategies to combat the COVID-19 pandemic by implementing standardized serology testing. It aims to validate assays and manufacture drug substances while conducting stability studies and pharmacokinetic analyses. The project also includes consulting services for developing bioanalytical methods and regulatory support for clinical-stage projects. By leveraging advanced biomedical computational science, the research seeks to provide comprehensive data resources for effective disease management.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals affected by COVID-19 or those involved in public health initiatives related to the pandemic.
Not a fit: Patients who are not impacted by COVID-19 or who do not participate in public health programs may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective public health interventions and improved management of COVID-19.
How similar studies have performed: Previous research has shown success in using standardized testing to inform public health responses during infectious disease outbreaks.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Briscoe, Lynn — Leidos Biomedical Research, INC.
- Study coordinator: Briscoe, Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.